Moleculin Biotech Inc (MBRX)

[king oil]

thanks very much for the additional info and the warm welcome!

I've taken small starter position and will keep researching. Seems like this one is flying below the radar in terms of message boards, coverage, etc. The only red flags I've found so far are that the original developers of the drug abandoned it (for lack of funding) and the paid promotion that the company did after the IPO (sometimes a tactic of the pump and dump penny stocks). The negative outcomes from previous trials were cases where the drug destroyed the tumors so quickly the body couldn't eliminate the waste fast enough. Unfortunately the patients died as a result. That can probably be addressed with changing the dosages.